These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 14527243

  • 1. Examining the FDA's oversight of direct-to-consumer advertising.
    Gahart MT, Duhamel LM, Dievler A, Price R.
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-120-3. PubMed ID: 14527243
    [Abstract] [Full Text] [Related]

  • 2. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H.
    Int J Health Policy Manag; 2015 Aug 25; 4(12):813-21. PubMed ID: 26673465
    [Abstract] [Full Text] [Related]

  • 3. The federal regulation of prescription drug advertising and promotion.
    Kessler DA, Pines WL.
    JAMA; 1990 Nov 14; 264(18):2409-15. PubMed ID: 2231998
    [Abstract] [Full Text] [Related]

  • 4. The educational potential of direct-to-consumer prescription drug advertising.
    Kaphingst KA, DeJong W.
    Health Aff (Millwood); 2004 Nov 14; 23(4):143-50. PubMed ID: 15318574
    [Abstract] [Full Text] [Related]

  • 5. Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role?
    Waxman HA.
    Health Aff (Millwood); 2004 Nov 14; Suppl Web Exclusives():W4-256-8. PubMed ID: 15452002
    [Abstract] [Full Text] [Related]

  • 6. Is the information "fair and balanced" in direct-to-consumer prescription drug websites?
    Huh J, Cude BJ.
    J Health Commun; 2004 Nov 14; 9(6):529-40. PubMed ID: 15764451
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Report criticizes FDA's oversight of DTC ads.
    Young D.
    Am J Health Syst Pharm; 2003 Jan 15; 60(2):122, 126. PubMed ID: 12561655
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A decade of direct-to-consumer advertising of prescription drugs.
    Donohue JM, Cevasco M, Rosenthal MB.
    N Engl J Med; 2007 Aug 16; 357(7):673-81. PubMed ID: 17699817
    [Abstract] [Full Text] [Related]

  • 14. Direct-to-physician and direct-to-consumer advertising: Time to have stringent regulations.
    Kannan S, Gowri S, Tyagi V, Kohli S, Jain R, Kapil P, Bhardwaj A.
    Int J Risk Saf Med; 2015 Aug 16; 27(2):77-83. PubMed ID: 26410010
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A review of FDA warning letters and notices of violation issued for patient-reported outcomes promotional claims between 2006 and 2012.
    Symonds T, Hackford C, Abraham L.
    Value Health; 2014 Jun 16; 17(4):433-7. PubMed ID: 24969004
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Promotion of prescription drugs to consumers.
    Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM.
    N Engl J Med; 2002 Feb 14; 346(7):498-505. PubMed ID: 11844852
    [Abstract] [Full Text] [Related]

  • 20. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
    Adams C.
    J Med Internet Res; 2016 Feb 18; 18(2):e33. PubMed ID: 26892749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.